• 제목/요약/키워드: Immunization

검색결과 693건 처리시간 0.02초

An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices

  • Cho, Hee-Yeon
    • Clinical and Experimental Pediatrics
    • /
    • 제55권1호
    • /
    • pp.1-5
    • /
    • 2012
  • The need for evidence-based decision making in immunization programs has increased due to the presence of multiple health priorities, limited human resources, expensive vaccines, and limited funds. Countries should establish a group of national experts to advise their Ministries of Health. So far, many nations have formed their own National Immunization Technical Advisory Groups (NITAGs). In the Republic of Korea, the Korea Expert Committee on Immunization Practices (KECIP), established by law in the early 1990s, has made many important technical recommendations to contribute to the decline in vaccine preventable diseases and currently functions as a NITAG. It includes 13 core members and 2 non-core members, including a chairperson. Core members usually come from affiliated organizations in internal medicine, pediatrics, obstetrics, microbiology, preventive medicine, nursing and a representative from a consumer group, all of whom serve two year terms. Non-core members comprise two government officials belonging to the Korea Centers for Disease Control and Prevention (KCDC) and the Korea Food and Drug Administration. Meetings are held as needed, but at least twice a year, and sub-committees are formed as a resource for gathering, analyzing, and preparing information for the KECIP meetings. Once the sub-committees or the KCDC review the available data, the KECIP members discuss each issue in depth and develop recommendations, usually by a consensus in the meeting. The KECIP publishes national guidelines and immunization schedules that are updated regularly. KECIP's role is essentially consultative and the implementation of their recommendations may depend on the budget or current laws.

Application of Program Theory and Logic Model to Evaluate Immunization Disparity Program for Children under 3 Years

  • Chung, Jee In
    • 보건행정학회지
    • /
    • 제32권3호
    • /
    • pp.272-281
    • /
    • 2022
  • With the outbreak of coronavirus disease 2019 (COVID-19) pandemic, health policymakers are adopting new policies regarding the issue of immunization disparities, especially for children in low-income communities of color who lack awareness and thereby access to vaccines. The purpose of this paper is to propose an evaluation framework using program theory-based evaluation approach and logic model to analyze and evaluate the immunization disparities in children aged 19-35 months. Data is collected from New York City department of Health and the U.S. Census Bureau for Northern Manhattan Start Right Coalition program which consists of 19,800 children, and the community-provider partnership includes 26 practices and 20 groups. Program theory is used to evaluate this community-based initiative with the logic model which is a visual depiction that illustrations the program theory to all stakeholders. The logic model highlights the resources, activities, outputs, outcomes, and impacts of the program to guide to planners and evaluators and to call attention to the inadequacies or flaws in the operational, implementation and service delivery process of the program in offering a new perspective on the program. This framework adds to the literature on evaluations of immunization disparities in determining whether evaluators can definitively attribute positive immunization outcomes in the community to the program and conclude whether it has potential in expanding or duplicating it to other similar settings, especially in other rural areas of the United States, and abroad, where routine immunization equity gaps are wide due to income, racial and ethnic diversity, and language barrier.

예방접종 홍보광고 전략개발 조사연구 (A Study on the Development of the Advertising Strategy and Public Service Announcement Materials for National Immunization)

  • 오국환;이무식;김병희;나백주;김건엽;홍지영;김영택;고재영;김영숙;이석구;조형원
    • 농촌의학ㆍ지역보건
    • /
    • 제30권2호
    • /
    • pp.183-204
    • /
    • 2005
  • 본 연구 목적은 예방접종에 대한 교육홍보 기본 컨셉 도출, 매체 집행전략 개발, 매체시안 개발을 위해 광고전략 조사를 실시하여, 2000년대에 국가예방접종사업의 홍보고안을 위한 효과적인 전략을 제시코자 실시하게 되었다. 연구대상과 방법으로 우리나라 보건소 242개 중 169개 보건소에 종사하는 예방접종 담당자(242명)와 자녀의 예방접종을 위해 보건소에 내소한 보호자(1,193명)를 대상으로 구조화된 우편 설문조사를 실시하여 예방접종에 대한 주관적 중요도, 예방접종 사업에 대한 홍보 경험 및 수단, 예방접종에 대한 지식과 인식, 예방접종 홍보광고 전략개발을 위한 방안을 도출하기 위해 빈도 분석, t-검정, 일원분산분석을 각각 실시하였다. 조사결과로 예방접종 담당자는 예방접종에 대한 중요성을 인식하고 있는 것으로 나타났다. 예방접종 사업의 홍보 매체 경험율에 대해서는 예방접종 담당자는 91.3%, 보호자는 70.6%가 경험이 있다고 응답하였고, 일반대중이나 광고 전문인 모두 자주 접할 수 있는 TV, 지역신문, 팜프렛 등의 홍보광고 수단을 경험한 것으로 조사되었다. 예방접종에 대한 지식과 인식에 대한 조사에서는 예방접종 담당자가 예방접종에 대한 전문적인 지식을 갖고 있는 것으로 나타났고, 보호자는 예방접종에 대한 필요성과 중요성을 높게 인식하고 있는 것으로 조사되었다. 예방접종 홍보매체의 선호도에서는 예방접종 담당자가 팜프렛 76.0%, 포스터 44.6% 순으로 나타났고 보호자는 TV 70.5%, 지역신문 39.2% 순으로 선호하는 것으로 나타났다. 광고 포스터 색상 선호도 조사에서는 예방접종 담당자가 초록 32.0%, 노랑 19.9% 순이었고, 보호자 역시 초록 29.5% 노랑 22.0% 순으로 나타났다. 광고 스타일 선호도 조사에서는 예방접종 담당자는 유명인사나 연예인이 예방접종으로 인해 일상생활이 활기차고 건강하다는 생활 장면을 보여주는 스타일로 구성해야 함을 알 수 있었다. 캠페인용 슬로건의 선호도 조상에서는 예방접종 담당자와 보호자 모두 긍정적 메시지를 선호하였다. 연구를 통해 예방접종 사업의 중단기 홍보전략에 대한 실행방안 구체화와 비교평가를 통한 가장 효율적인 홍보 방안을 제시하기 위한 연구사업이 필요하며 이를 위해 현실적 대중 요구를 반영한 홍보매체 개발, 홍보전략에 근거한 홍보매체 개발, 매체에 대한 평가연구, 연구방법 및 평가가 요구된다. 또한 교육홍보매체에 활용될 표준매체 제작 및 집행지침의 개발이 필요하다고 할 수 있다. 무엇보다도 이러한 사업의 추진을 위해서는 정부 또는 국가 공공기관의 예산 투자, 인력 투입과 활용 등을 통해 국가 예방 접종 사업이 활성화되길 기대한다.

  • PDF

보건소 예방접종 전산프로그램의 운영 현황 분석 (Evaluation on the implementation of the immunization registry program at the Public Health Centers)

  • 이건세;이석구;이무식;신의철;김영택;이연경
    • 보건행정학회지
    • /
    • 제13권2호
    • /
    • pp.67-84
    • /
    • 2003
  • Immunization has been one of the most effective measures preventing from infectious diseases. However, children routine vaccination rate of Korea was 68.2% and it was not higher than expected. Korean government revised the School Health Law for every primary school children to submit the vaccination certificate record from 2005. It is quite important national Infectious disease prevention policy to keep the immunizations rate high and monitor the immunizations rate continuously. To do this, National Institute of Health introduced the National Immunization Registry(NIR) Program at 2000. Objective : The aims of this study was to evaluate the Immunization Registry program which has been implementing since 2000 at the Public Health Centers(PHC). Methods : The mail survey was done from November 2001 to January 2002. 169 (69%) Public Health Centers among 244 PHC were responded. Results : The respondents of PHC sud the Immunization Registry(IR) program had reduced the workload (18.5%). 69.2% said they inputted the immunization data into the IR program after the shots were given. 86.5% said they hadn´t checked or retrieved the children lists who had missed the scheduled immunization. Only 17.2% said the speed of internet for the R program was good. It showed that 20% of respondents hadn´t written down documents, records on immunization any more. Even there were a lot of negative results, the respondents of PHC thought that the IR program was effective. They especially agreed that the IR program could make the job accurate (81.5%), convenient (71.3%), and reduced the chances of making mistakes (71.3%), increase the service quality (78.5%). And they were well adapting the job process of the IR (79.63%). Bivariate analysis showed that the software program was the important determinants of IR success. The only Bit Computer software program has been evaluated to be less satisfactory than the Integrated (Posdata operating system + Bit software) program. Other variables, such as age, duration of present job, and location of PHC (metropolitan, small city, rural area) were not significantly related. Conclusion : It seemed that the success of NIR might depend on the software program. Because Integrated program, which has been developed from 1994, include not only the general operating and management program for PHC but also IR program. It was natural to prefer Integrated program to Bit software program. So we can suggest that it is essential for the NIR to be successful that not only the immunization software program but also hardware equipments and public health information system should be further improved.

신장이식 환자의 인플루엔자 예방접종 실태와 이행 영향 요인 (Current Immunization Status and Factors Affecting the Influenza Vaccination in Kidney Transplant Patients)

  • 조한경;정재심;문성미;김미나
    • Journal of Korean Biological Nursing Science
    • /
    • 제18권2호
    • /
    • pp.118-125
    • /
    • 2016
  • Purpose: The present study examines the current influenza immunization rate among kidney transplant patients in an effort to identify the factors influencing their decisions pertaining to the immunization. Methods :Participants in the study included 150 adults over the age of 64 years who visited a General Surgery Department in Korea on April 2015, who had had a kidney transplant at least two years prior to the visit. We compared the characteristics of transplant patients who were immunized against those of the patients who had not been immunized. Results: The average age of the participants was $48.5{\pm}9.6years$, consisting of 87 males (58.0%) and 63 females (42.0%). The average post-surgery period was $91.0{\pm}59.0months$. Between September and December 2014, the immunization rate among these participants was 61.3%. Factors which influenced the participant's decision to get immunized in 2014 and drove up the immunization rate were: previous immunization in 2013 (OR=24.57, CI= 8.79-68.70, p<.001), marital status (OR=3.33, CI 1.05-10.56, p=.041), and awareness (OR=1.58, CI=0.99-2.52, p=.056). Conslusion: The current study found that the previous year's immunization record, marital status, and awareness increased the rate of immunization among the participants.

Impacts of Host Immunization on the Translocation of Intestinal Bacteria and Growth Performance in Weanling Piglets

  • Moon, H.K.;Hanz, In K.;Gentry, J.L.;Parmentier, H.K.;Schrama, J.W.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제12권2호
    • /
    • pp.180-185
    • /
    • 1999
  • Effects of host immunization on bacterial translocation and growth performance in weanling piglets were studied. Twenty four barrows were assigned to one of two immunization treatments: Control group (CON: immunized with placebo) or Immunization group [IMMU: immunized with Antigen cocktail; Keyhole limpet hemocyanin (KLH), Ovalbumin (OA), and Tetanus toxoid (TT)]. On d0, piglets were weaned and intramuscularly immunized with 2 ml of placebo or Antigen cocktail, respectively. Antigen-specific Ig titers were determined by ELISA (Enzyme Linked ImmunoSorbent Assay). Ig titers to E. coli-derived lipopolysaccharides (LPS) were measured as the indicator of bacterial translocation. Ig titers to LPS were higher (p<0.10, 0.05 or 0.01) in CON group before immunization (d0), but the difference disappeared with time and IgA titers to LPS became higher (p<0.05) in IMMU group on d39. In IMMU group, IgG titers to LPS from d28 onwards showed positive correlations (p<0.10, 0.05, 0.01 or 0.001) with IgG titers to KLH from d11 onwards and with IgM titers to KLH from d7 onwards. Generally, growth performance was negatively related to IgG titers to LPS. Average daily gain for d28 to d35 showed negative correlations (p<0.10, 0.05, or 0.01) with IgG titers to LPS on d28 onwards in immunization group. These results reveal some evidences that host immunization might facilitate bacterial translocation and high humoral immune responses to LPS are negatively related with the growth performance.

Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018

  • Choi, Eun Hwa;Park, Su Eun;Kim, Yae-Jean;Jo, Dae Sun;Kim, Yun-Kyung;Eun, Byung-Wook;Lee, Taek-Jin;Lee, Jina;Lee, Hyunju;Kim, Ki Hwan;Cho, Hye-Kyung;Cho, Eun Young;Kim, Jong-Hyun
    • Clinical and Experimental Pediatrics
    • /
    • 제62권7호
    • /
    • pp.252-256
    • /
    • 2019
  • The Committee on Infectious Diseases of the Korean Pediatric Society recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization guideline. This report provides the revised recommendations made by the committee and summarizes several changes from the 2015 guideline. National immunization program (NIP) launched a human papillomavirus (HPV) immunization for girls aged 12 years in 2016. NIP has also expanded age indication for inactivated influenza vaccine (IIV) to 12 years of age in the 2018-2019 season. Quadrivalent IIVs with a full dose (0.5 mL) are approved for all children of 6 months or older. Recommendations of live attenuated influenza vaccine were removed. For inactivated Japanese encephalitis vaccine, first 2 doses are considered as the primary series. Recommendations for use of newly introduced vaccines (diphtheria-tetanus-acellular pertussis/inactivated poliovirus/Haemophilus influenzae type b, 9-valent HPV, new varicella vaccine, new quadrivalent IIV, and attenuated oral typhoid vaccine) were added. Lastly, monitoring system for adverse events following immunization was updated. Other changes can be found in the 9th edition of Immunization guideline in detail.

The Molecular Characterization of Serogroup C Neisseria meningitidis Strains Circulating in Beijing

  • Zhang, Tie-Gang;He, Jing-Guo;He, Xiong;Chen, Li-Juan;Shao, Zhu-Jun;Sun, Mei-Ping
    • Journal of Microbiology
    • /
    • 제44권6호
    • /
    • pp.685-688
    • /
    • 2006
  • The aim of this study was to characterize the molecular features of serogroup C Neisseria meningitidis strains circulating in Beijing, China. Twenty out of 23 strains belonged to ST 4821. The causative serosubtype for meningococcal meningitis was P1.12-1,16-8. All of the strains expressed class 3 PorB protein. Among the five pulsed-field gel electrophoresis patterns observed, pattern III predominated.

Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity

  • Shim, Byoung-Shik;Choi, Youngjoo;Cheon, In Su;Song, Man Ki
    • IMMUNE NETWORK
    • /
    • 제13권3호
    • /
    • pp.81-85
    • /
    • 2013
  • The mucosal surfaces are constantly exposed to incoming pathogens which can cause infections that result in severe morbidity and/or mortality. Studies have reported that mucosal immunity is important for providing protection against these pathogens and that mucosal vaccination is effective in preventing local infections. For many years, the sublingual mucosa has been targeted to deliver immunotherapy to treat allergic hypersensitivities. However, the potential of vaccine delivery via sublingual mucosal has received little attention until recently. Recent studies exploring such potential have documented the safety and effectiveness of sublingual immunization, demonstrating the ability of sublingual immunization to induce both systemic and mucosal immune responses against a variety of antigens, including soluble proteins, inter particulate antigens, and live-attenuated viruses. This review will summarize the recent findings that address the promising potential of sublingual immunization in proving protection against various mucosal pathogens.

Transcutaneous antigen delivery system

  • Lee, Mi-Young;Shin, Meong-Cheol;Yang, Victor C.
    • BMB Reports
    • /
    • 제46권1호
    • /
    • pp.17-24
    • /
    • 2013
  • Transcutaneous immunization refers to the topical application of antigens onto the epidermis. Transcutaneous immunization targeting the Langerhans cells of the skin has received much attention due to its safe, needle-free, and noninvasive antigen delivery. The skin has important immunological functions with unique roles for antigen-presenting cells such as epidermal Langerhans cells and dermal dendritic cells. In recent years, novel vaccine delivery strategies have continually been developed; however, transcutaneous immunization has not yet been fully exploited due to the penetration barrier represented by the stratum corneum, which inhibits the transport of antigens and adjuvants. Herein we review recent achievements in transcutaneous immunization, focusing on the various strategies for the enhancement of antigen delivery and vaccination efficacy.